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Autosomal-Recessive Hearing Impairment
Due to Rare Missense Variants within S1PR2
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Joshua D. Smith,11 Deborah A. Nickerson,11 Michael J. Bamshad,11 University of Washington Center
for Mendelian Genomics, Sheikh Riazuddin,7,12,13 Wasim Ahmad,4 Thomas B. Friedman,2
and Suzanne M. Leal1,*
The sphingosine-1-phosphate receptors (S1PRs) are a well-studied class of transmembrane G protein-coupled sphingolipid receptors that
mediate multiple cellular processes. However, S1PRs have not been previously reported to be involved in the genetic etiology of human
traits. S1PR2 lies within the autosomal-recessive nonsyndromic hearing impairment (ARNSHI) locus DFNB68 on 19p13.2. From exome
sequence data we identified two pathogenic S1PR2 variants, c.323G>C (p.Arg108Pro) and c.419A>G (p.Tyr140Cys). Each of these var-
iants co-segregates with congenital profound hearing impairment in consanguineous Pakistani families with maximum LOD scores of
6.4 for family DEM4154 and 3.3 for family PKDF1400. Neither S1PR2missense variant was reported among ~120,000 chromosomes in
the Exome Aggregation Consortium database, in 76 unrelated Pakistani exomes, or in 720 Pakistani control chromosomes. Both DNA
variants affect highly conserved residues of S1PR2 and are predicted to be damaging by multiple bioinformatics tools. Molecular
modeling predicts that these variants affect binding of sphingosine-1-phosphate (p.Arg108Pro) and G protein docking (p.Tyr140Cys).
In the previously reported S1pr2/ mice, stria vascularis abnormalities, organ of Corti degeneration, and profound hearing loss
were observed. Additionally, hair cell defects were seen in both knockout mice and morphant zebrafish. Family PKDF1400 presents
with ARNSHI, which is consistent with the lack of gross malformations in S1pr2/mice, whereas family DEM4154 has lower limb mal-
formations in addition to hearing loss. Our findings suggest the possibility of developing therapies against hair cell damage (e.g., from
ototoxic drugs) through targeted stimulation of S1PR2.Sphingosine-1-phosphate (S1P) is one of the most studied
sphingolipids due to its multiple roles in cellular prolifera-
tion, inflammation, migration, cytoskeletal organization,
and angiogenesis that are mediated by either intracellular
targets (e.g., class-I histone deacetylases) or one of five
transmembrane G protein-coupled receptors (GPCRs),
namely S1PR1–5.1 Over the past 20 years, the tissue distri-
bution of these five receptors and the phenotypes of
knockout mice for each S1PR have been well docu-
mented,1 such as vascular phenotypes for S1PR1,2 deafness
for S1PR2,3–5 small litter size for S1PR3,6 atypical megakar-
yocytes for S1PR4,7 and lack of peripheral monocytes for
S1PR5.8 In humans, pathogenic variants have not been re-
ported for any of the S1PRs.
Previously, the autosomal-recessive (ar) hearing impair-
ment (HI) in Pakistani family DEM4154 was mapped to
the DFNB68 locus (MIM: 610419) on chromosome
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The Americpoint LOD score of 4.6 (Figure 1A).9 Family DEM4154
segregates both congenital profound HI and limb malfor-
mations but no other abnormalities. Audiometric data ob-
tained from hearing-impaired individual V-4 of family
DEM4154 showed profound hearing loss at all frequencies
(Figure 1B). Within the mapped region lies S1PR2 (MIM:
605111), a gene for which knockout mice and zebrafish
models were previously shown to have inner ear structural
alterations and hearing loss.3–5,10
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Figure 1. Pedigree Drawings, Mutation
Information, and Audiograms for Families
with S1PR2 Variants
(A) Family DEM4154 with the c.323G>C
(p.Arg108Pro) variant. Individuals whose
DNA samples were submitted for exome
sequencing are marked with asterisks.
The mapped interval from linkage
analysis and homozygosity mapping lies
between D19S1034 and D19S433 (6.11–
30.42 Mb). Note that a ZNF91 variant
(23.56 Mb) does not segregate with hear-
ing impairment, therefore reducing the
mapped interval to 17.45 Mb.
(B) Air-conduction audiograms for indi-
viduals V-4 of family DEM4154 (solid
lines) and IV-1 and IV-3 of family
PKDF1400 (arrows denote residual hear-
ing). Red circles, right ear; blue crosses,
left ear. Age (years) at audiometry: 4154
V-4, 20; PKDF1400 IV-1, 19; PKDF1400
IV-3, 12. All three individuals have
congenital, profound hearing loss across
all frequencies.
(C) Chromatograms comparing an HI in-
dividual who is homozygous for each
S1PR2 variant, a heterozygous carrier,
and a hearing individual.
(D) Family PKDF1400 with the c.419A>G
(p.Tyr140Cys) variant and STR haplotype segregating with hearing impairment. The mapped interval from linkage analysis and
homozygosity mapping lies between D19S884 and D19S885 (8.15–16.21 Mb), so the length of the mapped interval is 8.06 Mb.submitted for exome sequencing at the University of
Washington Center for Mendelian Genomics to an average
read depth of 773 and 583, respectively. For both samples,
sequence capture was performed in solution with the
Roche NimbleGen SeqCap EZ Human Exome Library
v.2.0 (~37 Mb target). Fastq files were aligned to the hg19
human reference sequence using Burrows-Wheeler Aligner
(BWA)11 to generate demultiplexed BAM files. Realign-
ment of indel regions, recalibration of base qualities, and
variant detection and calling were performed using the
Genome Analysis Toolkit (GATK)12 to produce VCF files.
Annotation was performed with SeattleSeq 137.
Rare homozygous variants that are shared by the two
hearing-impaired individuals and are predicted to be
damaging were identified from exome data using informa-
tion on genotype status, variant quality control (QC), and
annotation from RefSeq, SeattleSeq, dbSNP, the Exome
Aggregation Consortium (ExAC), and dbNSFP v.2.913 (Ta-
ble 1). Across the 22 autosomes, only six coding variants
were identified to be homozygous in both DEM4154 indi-
viduals with HI, passed QC, and had a minor allele fre-
quency (MAF) < 0.01 among South Asian ExAC alleles.
All six variants were missense and occurred on chromo-
some 19, but only three variants occurred within the map-
ped region and co-segregate with HI (Table 1). Of the three
co-segregating variants within 19p13.2, only the
c.323G>C (p.Arg108Pro) variant within S1PR2 (Figures
1A and 1C) was not found in dbSNP and ExAC, occurs at
a highly conserved residue, and is predicted to be delete-
rious in all available bioinformatics results (Table 1). For
the S1PR2 variant, a maximum two-point LOD score14 of332 The American Journal of Human Genetics 98, 331–338, February6.4 was obtained at W ¼ 0. A higher LOD score than in
the original mapping of DFNB68 in family DEM4154 was
obtained for the S1PR2 variant due to the very low allele
frequency of the variant and the inclusion of an additional
family member V-6 (Figure 1A) who was born after the
family was initially ascertained. Furthermore, Sanger
sequencing of the S1PR2 c.323G>C variant in 720 Pakis-
tani control chromosomes and our in-house exome
sequence data from 76 unrelated Pakistani individuals
with non-HI Mendelian phenotypes were both negative
for the S1PR2 variant.
Subsequently, the arHI in another consanguineous
family, PKDF1400 (Figure 1D), was mapped to the
DFNB68 region. Multipoint linkage analysis using STR
marker genotypes revealed a maximum multipoint LOD
score of 3.3 on chromosome 19p13.2–p13.12 (Figure 1D).
For this family, a second locus wasmapped to chromosome
1q23.3–q25.2 with a multipoint LOD score of 2.1 (data not
shown). Audiograms for two hearing-impaired individuals
of PKDF1400 both show profound hearing loss across all
frequencies (Figure 1B). Careful phenotyping of hearing-
impaired individuals ruled out any skeletal, immunologic,
cardiovascular, or endocrine features. No history of sei-
zures or vestibular defects was detected in any members
of family PKDF1400, further supporting the diagnosis of
autosomal-recessive nonsyndromic (ARNS) HI.
For PKDF1400, sequence capture was performed with
the Illumina Nextera Rapid Capture Enrichment Kit to
create libraries. DNA samples of hearing-impaired siblings
IV-1 and IV-2 were exome sequenced at an average depth
of 653 and 773, respectively. Sequence reads were also4, 2016
Table 1. Homozygous Variants on Chromosome 19 from Exome Data of Families DEM4154 and PKDF1400
Family DEM4154a PKDF1400b
hg19 Position 9,088,370 10,335,259 13,007,757 23,557,526 36,558,235 38,055,877 9,082,634 10,335,163
Genomic region 19p13.2 19p13.2 19p13.2 19p12 19q13.12 19q13.12 19p13.2 19p13.2
Reference allele T C G G G G T T
Alternate allele G G A A A A C C
Gene MUC16c S1PR2 GCDHd ZNF91 WDR62 ZNF571 MUC16c S1PR2
MIM 606154 605111 608801 603971 613583 NA 606154 605111
GenBank NM_024690.2 NM_004230.3 NM_000159.3 NM_003430.2 NM_173636.4 NM_016536.3 NM_024690.2 NM_004230.3
cDNA change c.3445A>C c.323G>C c.886G>A c.71C>T c.589G>A c.1453C>T c.9181A>G c.419A>G
Amino acid change p.Thr1149Pro p.Arg108Pro p.Gly296Ser p.Pro24Leu p.Val197Ile p.Arg485Cys p.Met3061Val p.Tyr140Cys
dbSNP rsID 532389640 NA 539505767 NA 535488873 139005348 571388611 NA
No. ExAC South
Asian alleles
62 het, 3 hom 0 61 het, 1 hom 0 31 het 15 het 56 het 0
ExAC South
Asian MAF
0.004 0 0.004 0 0.002 0.0002 0.003 0
ExAC all MAF 0.0006 0 0.0006 0 0.0003 0.0001 0.0005 0
MAF in-house
exomes (n ¼ 76)
0 0 0.013 0 0 0 0 0
GERP score 0.4 5.5 5.4 0.3 5.5 1.2 0.5 5.5
phastCons100way_
vertebrate
0 1.0 1.0 0.003 1.0 0 0 1.0
phyloP100way_
vertebrate
2.1 7.8 9.5 1.5 9.3 2.0 0.7 6.0
CADD score, scaled 0.9 21.7 21.3 0.002 28.9 11.0 0.001 22.9
Fathmm tolerated NA damaging tolerated tolerated tolerated tolerated tolerated
Likelihood ratio
test
NA damaging damaging NA damaging NA NA damaging
Logistic regression
(metaLR)
tolerated damaging damaging tolerated tolerated tolerated tolerated damaging
MutationAssessor non-functional,
neutral
functional,
medium
functional,
medium
non-functional,
neutral
non-functional,
low
functional,
medium
non-functional,
neutral
functional,
medium
MutationTaster NA disease-
causing
disease-
causing
polymorphism disease-
causing
polymorphism polymorphism disease-
causing
PolyPhen2 HVAR possibly
damaging
probably
damaging
probably
damaging
benign probably
damaging
benign benign probably
damaging
PROVEAN neutral deleterious deleterious neutral neutral deleterious neutral deleterious
SIFT damaging damaging damaging tolerated tolerated tolerated tolerated tolerated
Support Vector
Machine
(metaSVM)
tolerated damaging damaging tolerated tolerated tolerated tolerated damaging
Segregates with
phenotype
yes yes yes no no no yes yes
Abbreviations are as follows: NA, not available; ExAC, Exome Aggregation Consortium; het, heterozygous; hom, homozygous; MAF, minor allele frequency;
CADD, Combined Annotation Dependent Depletion. Conservation scores and bioinformatics results as compiled by dbNSFP v.2.9.
aVariants are homozygous in both hearing-impaired individuals V-4 and V-7 of family DEM4154. For either sample, within the mapped interval overall coverage
was 99.4%, with median depth of 453. Coverage at depth R153 was 85%.
bVariants are homozygous in both hearing-impaired siblings IV-1 and IV-2 from family PKDF1400. For both PKDF1400 samples, 80%–85% of the mapped interval
on chr19 was covered by R153.
cAlthough both DEM4154 and PKDF1400 have MUC16 missense variants, these variants have relatively high MAF in South Asian ExAC alleles, occur at non-
conserved residues, and are predicted benign by majority of available bioinformatics results. MUC16 variants have been identified previously in probands with
other Mendelian phenotypes but have been dismissed as non-causal due to the gene’s high polymorphic rate.40
dDEM4154 individuals who are homozygous for the GCDH variant do not have signs and symptoms of glutaric aciduria (MIM: 231670). The GCDH variant has
relatively high South Asian MAF.
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mapped against the hg19 human reference sequence using
BWA, with recalibration performed using the GATK pipe-
line. Variant calls were annotated with ANNOVAR. For
PKDF1400, within the mapped interval on chromosome
1q23.3–q25.2, no potentially causal variants were identi-
fied from exome data. On the other hand, within the
mapped interval on chromosome 19p13.2–p13.12, two
rare missense variants were shared by the two siblings (Ta-
ble 1), including S1PR2 c.419A>G (p.Tyr140Cys). Sanger
sequencing revealed that the S1PR2 variant segregates
with HI in family PKDF1400 (Figures 1C and 1D). The
c.419A>G (p.Tyr140Cys) variant occurs at a highly
conserved residue, is predicted to be deleterious, and is
absent in dbSNP and ExAC, in 720 Pakistani control
chromosomes, and in 76 Pakistani exomes with non-HI
phenotypes, whereas missense variant c.9181A>G
(p.Met3061Val) in MUC16 is present in both ExAC and
dbSNP and is predicted to be benign (Table 1). Overall
our findings support the contribution of S1PR2 variants
to the etiology of ARNSHI in humans.
Similar to what we observe in humans, S1pr2/ mice
had profound deafness as early as postnatal day 22.3–5
The deafness in mice was believed to be degenerative
rather than developmental because of the normal ap-
pearance of the inner ear prior to establishment of en-
docochlear potential and onset of hearing at the end of
week 2.3–5 Histologic analysis of the inner ears of knockout
mice demonstrated changes within the stria vascularis by
postnatal day 14, and degeneration of hair cells and spiral
ganglion neurons and overt signs of inner ear dysfunction
were obvious by 3 weeks of age.3–5 Likewise, in the zebra-
fish morphant in which translation is inhibited for miles-
apart, a homolog for S1PR2, lateral line hair cells were
absent or shrunken.10 Structural defects were also identi-
fied within the otic vesicle, the semicircular canals, oto-
liths, utricle, and saccule of morphant zebrafish.10 In the
S1pr2/ mouse, progressive deterioration of vestibular
epithelium and loss or deformity of utricular and saccular
otoconia were evident. The utricular otoconia abnormal-
ities were evident as early as P7 prior to manifestation of
behavioral balance abnormalities.3,4 In contrast, saccular
otoconia abnormalities became apparent later during
adulthood3,5 and correlated well with the behavioral
vestibular defects in S1pr2/mice as manifested by persis-
tent head tilting and poor swimming ability that became
more obvious with age.3–5 Due to the remote location of
families DEM4154 and PKDF1400, reliable documentation
by an experienced neurotologist of utricular and saccular
function through otolith-ocular reflexes or vestibular
evoked myogenic potentials15 was not available. On the
other hand, affected individuals of both families did not
present with obvious vestibular symptoms at any age.
The observation of vascular changes in the inner ear
prior to cochlear dysfunction is consistent with the role
of S1PR2 as a potent regulator of the inflammatory
response within vascular endothelium.16–19 S1PR1 and
S1PR2 cooperatively regulate embryonic vascular334 The American Journal of Human Genetics 98, 331–338, Februarypatterning20 and endothelial barrier function by influ-
encing the organization of F-actin and tight junction pro-
teins.21 Dysmorphology of stria vascularis marginal cells
and vasculature within the intermediate cell layer of
S1pr2-deficient mice might indicate the altered function
of these cell layers in the establishment of an endocochlear
potential.4 Loss of endocochlear potential, in turn, can
lead to deafness and subsequent degeneration of hair cells
and spiral ganglion neurons.3–5 In vitro, activation of
S1PR2 is necessary for phosphorylation of ezrin, radixin,
and moesin (ERM) proteins that link actin cortical
cytoskeleton to the plasma membrane and is therefore
important in cellular events that require cytoskeletal rear-
rangement such as filopodia formation.22 Interestingly,
mutation of radixin results in hearing loss and degenera-
tion of cochlear stereocilia in mice and humans.23,24 In
morphant zebrafish, knockdown of the S1PR2 homolog re-
sulted in reduced expression of several homologs for genes
involved in mouse and human HI, namely hmx2, fgf3,
pax2, and tmie.10 Independent mutations in these four
downstream genes in mice or humans result in otolith ab-
normalities, aplastic inner ears, or hair cell defects.25–28
Taken together, this body of evidence implies that S1PR2
can exert its influence on inner ear function through regu-
lation of inner ear fluid homeostasis or through changes in
expression of other essential inner ear proteins.
Within vascular endothelial cells, excess S1P ligand acti-
vates S1PR2 and the RhoA/ROCK pathway, resulting in
F-actin and tight junction disorganization.21 Additionally,
S1P induces neural progenitor cells to differentiate in the
presence of increased S1PR2 expression and phosphory-
lated MAPK/ERK.29 To determine whether the identified
mutations in the ARNSHI families affect S1PR2 function,
a structural model of S1PR2 was predicted with Phyre230
and SWISS-MODEL.31 The X-ray crystal structures of two
GPCRs, namely S1PR132 (PDB: 3V2W) or the b-2
adrenergic receptor33 (ADRB2; PDB: 3SN6), were used as
templates. Like most GPCRs, S1PRs consist of seven trans-
membrane helices (TM1–7) and three extracellular loops
(ECL1–3).32 The arginine and glutamic acid residues at po-
sitions 108–109 within TM3 at the extracellular side of
S1PR2 are identical in S1PRs and similar in GPCRs.
Arg120 and Glu121 of S1PR1, which are conserved as
Arg108 and Glu109 in S1PR2 (Figure S1A), were previously
identified as the most important residues for ligand bind-
ing for S1PR1.32,34,35 Alterations to these two residues led
to loss of S1P binding activity and ERK/Akt phosphoryla-
tion.34,35 For S1PR2, Arg108 and Glu109 are predicted to
directly interact with S1P, such that Glu109 binds the
amide group at the S1P linker while the positively charged
guanidino group of Arg108 forms two salt bridges with the
negatively charged phosphate head of S1P.32,34,35 At
resting state, Arg108 forms H-bonds with multiple resi-
dues, namely Leu92 at the extracellular end of TM2;
Thr97, Gln104, and Trp105 within ECL1; and Glu109 of
TM3 (Figure S1B). When changed to proline, the residue
is instead predicted to form a single H-bond with Ser1114, 2016
and to lose the side chain that projects into the binding
pocket in order to interact with S1P or with ECL1 and
TM2 residues (Figure S1B). Based on S1PR1 crystal struc-
ture, ECL1 and ECL2 are tightly packed against the N-ter-
minal helix in order to contribute surface area to the
ligand-binding pocket and to restrict S1P access, thereby
resulting in slow binding saturation when S1P is in
excess.34 The p.Arg108Pro variant would probably affect
packing of ECL1 onto the binding pocket, bundling of
TM2 against TM3, and proper positioning of Glu109 in or-
der to bind S1P. This suggests that the p.Arg108Pro variant
might not only affect direct interaction with S1P, but
might also change the structure and properties of the
ligand-binding pocket of S1PR2.
Like most GPCRs, extracellular binding of S1P to S1PR2
markedly increases affinity of S1PR2 for G protein from
the cytosol. Coupling of S1PR2 with three G proteins is
known to initiate signal transduction for several essential
pathways: (1) Gi for MAPK/ERK and Akt phosphorylation;
(2) Gq for phospholipase C activation; and (3) G12/13 for
activating the RhoA pathway and also adenylate cyclase
for cAMP synthesis.16 The p.Tyr140Cys variant occurs
within intracellular loop 2 (ICL2); based on the known
structure of the ADRB2-Gas complex, ICL2 interacts with
helices of the G protein and occupies about 25% of buried
surface area or interaction points.33 Additionally, Tyr140
aligns with Tyr141 of ADRB2 (Figure S1A), which is one
of three amino acids that facilitate docking of ADRB2
into a hydrophobic pocket of G protein and stabilize the
ICL2 helix.33 For S1PR2, the p.Tyr140Cys variant might
result in the gain of an H-bond between Arg130 and
Gly141 (Figure S1C). The Arg130 residue within ICL2 of
S1PR2 aligns with ADRB2 Arg131 (Figure S1A), which con-
tributes to packing of ICL2 against TM3 and TM7 of the re-
ceptor.33 Loss of the aromatic ring of tyrosine due to the
p.Tyr140Cys variant is therefore predicted to interfere
with receptor docking and ICL2 stability.
From these modeling predictions, it is hypothesized that
S1PR2 variants result in either loss of activation of S1PR2
by S1P ligand or non-formation of the S1PR2-G protein
complex. Both events would result in failed phosphoryla-
tion of the MAPK/ERK pathway, which would (1) affect
transcription or translation of several inner ear proteins
and thereby cause structural defects of the cochlea,
otoconia, or hair cells3–5,10 and (2) result in non-phosphor-
ylation of ERM proteins, which colocalize with S1PR2-acti-
vated RhoA in order to maintain tight cell junctions.21,22
Loss of S1PR2 function is expected to result in inflamma-
tion and hyperpermeability of the stria vascularis at onset
of hearing function,21 which can then cause loss of
endocochlear potential, hearing loss, and eventually
degeneration of inner ear structures.3–5 Although S1PR2
also induces neural differentiation via phosphorylated
MAPK/ERK,29 knockout mice have apparently normal
hair cells and spiral ganglia in the first 2 weeks of life prior
to degeneration,3–5 indicating that failed differentiation of
neural cells in the inner ear is not part of the S1PR2 defect.The AmericPreviously, the ARNSHI in a second unrelated, consan-
guineous Pakistani family (DEM4100) was also mapped to
the DFNB68 locus with a maximummultipoint LOD score
of 4.8.9 However, Sanger sequencing revealed no poten-
tially causal variant within S1PR2, although a putatively
pathogenic variant c.690delT (p.Gly231Valfs*10) was iden-
tified in ESRRB (MIM: 602167; GenBank: NM_004452.3), a
gene that is known to be involved in ARNSHI (Figure S2).36
This ESRRB deletion is predicted to initiate nonsense-medi-
ated decay37 and is absent in ExAC, 76 in-house exomes,
and 174 Pakistani control chromosomes.
For family DEM4154, lower limb deformities were also
detected in all hearing-impaired individuals (Figure S3).
These limb deformities are not similar to any phenotypes
previously observed, with various asymmetric skeletal de-
fects from absence or shortening of leg bones to overlap-
ping, missing, or fused digits. Surprisingly, all the hands
of affected individuals appear to have long fingers and
possibly fifth digit camptodactyly (Figure S3). It was
initially thought that the lower limb deformities do not
co-occur with HI due to the lack of obvious deformities
in hearing-impaired individual V-7 (Figure 1A). However,
X-ray findings of this individual’s feet and knees
confirmed mild deformities on the right (Figure S3). Gross
limb deformities were not observed in family PKDF1400 or
S1pr2/ mice, which clearly delineate S1PR2’s involve-
ment in ARNSHI. We believe that the limb deformities in
family DEM4154 are not due to the S1PR2 c.323G>C
(p.Arg108Pro) variant but are instead due to a variant in
another gene. Within the mapped interval, there are
~400 RefSeq genes, but we identified only six coding vari-
ants (Table 1) as homozygous in both individuals V-4, who
has hearing impairment and severe foot and leg defor-
mities, and V-7, who has hearing impairment and mild
foot/knee deformity (Figure S3). Several genes within the
mapped interval have been previously associated with
limb abnormalities (Table S1), including EPS15L138 for
which exome coverage was incomplete. However, Sanger
sequencing of the 50 UTR and missing coding regions of
EPS15L1 did not reveal potentially causal variants. Across
the exome we examined the data for variants that are ho-
mozygous in both individuals V-4 and V-7 or homozygous
in V-4 but not in V-7 by following up identified variants
with Sanger sequencing, but no potentially causal variants
were identified. Additionally we did not identify poten-
tially causal variants in genes outside the mapped interval
that have been associated with limb defects. Our findings
in family DEM4154 demonstrate that not all families with
co-occurrence of phenotypes are due to syndromic disease
and some warrant investigation to find unique causal var-
iants for each phenotype.
In conclusion, the identification of two unique, delete-
rious variants within S1PR2, each of which segregates
with HI in unrelated families, and the occurrence of inner
ear abnormalities without other gross malformations in
family PKDF1400 or in knockout mice support the
involvement of S1PR2 in ARNSHI. Recently the stonedeafan Journal of Human Genetics 98, 331–338, February 4, 2016 335
(stdf) mouse that was homozygous for missense variant
S1pr2 c.866C>G (p.Thr289Arg) was reported to have se-
vere-to-profound hearing impairment, cochlear hair cell
loss, changes in the stria vascularis, and reduced endoco-
chlear potential, but no limb abnormalities (K.P. Steel,
personal communication). The association of S1PR2 vari-
ants with ARNSHI in humans establishes S1PR2 as an
essential inner ear protein and a plausible drug target for
inner ear disease. It has been suggested that, in the
absence of functional S1PR2, the difference in onset of
vascular versus histologic changes in the inner ear pre-
sents a ‘‘therapeutic window’’ for selective S1PR2 agonist
activity to prevent cochlear degeneration and vestibular
deficits in mice.3,4 However, current evidence indicates
multiple functions of S1PR2 by affecting translation or as-
sembly of other proteins that are essential to inner ear
function and might imply that the vascular and histologic
changes are not sequential but rather are concomitant.
Unlike in mice there is no documentation of progressive
vestibular deficits in humans with S1PR2 variants,
although congenital deafness begins at fetal stage in hu-
mans; therefore, at this point drug targeting of S1PR2-
mediated pathways cannot be directly applied to amelio-
ration of genetic inner ear defects. On the other hand,
there is evidence in mice that S1P protects against hair
cell loss from gentamicin ototoxicity via S1PR2,39 so it is
possible that targeted stimulation of S1PR2 can be used
to attenuate the harmful effects of ototoxic drugs on
hair cells within the human inner ear.Accession Numbers
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